No Data
No Data
No Data
New Stock News | Too Beautiful Medical Technology submits secondary listing application to HKEx as a provider of digital solutions for the medical science industry.
According to the information provided by Zhuo Shi Consulting, Tai Mei Medical Technology is the only supplier in China's medical industry that can provide a one-stop digital solution from R&D to marketing.
Both Tencent and SoftBank have invested! TaiMei Medical Technology has successfully filed for an IPO on the Hong Kong Stock Exchange after previously failing on the Star Market.
Taimei Medical received the notice of acceptance from China Securities Regulatory Commission for its IPO on Hong Kong Stock Exchange, with the issuance of no more than 0.135 billion shares, and the shareholders behind it include Tencent, SoftBank China, etc. Currently, Taimei Medical is still in a loss state. Its previous application for IPO on the STAR market was rejected by the Shanghai Stock Exchange due to issues such as the attributes of the STAR market and the sustainability of the income.
Tai Mei Medical Technology plans to go public in Hong Kong and has received the notice of record filing from the China Securities Regulatory Commission. It plans to issue no more than 135 million shares.
According to the new regulations for domestic enterprises' overseas listing filing effective on March 31, 2023, the original pre-listing disclosure documents will become history for enterprises choosing H-shares listing in Hong Kong. The filing notice will replace the pre-listing disclosure documents for overseas listed companies.
IPO News | Taimei Technology's proposed Hong Kong stock IPO, China Securities Regulatory Commission requested clarification on matters such as reasons for the large difference in shareholders' share transfer prices between the two
On March 1, the China Securities Regulatory Commission announced the requirements for supplementary materials for overseas issuance and listing registration (February 23, 2024 to February 29, 2024).
Taimei Medical Technology, from Jiaxing, Zhejiang, submitted an IPO prospectus to go public in Hong Kong, co-sponsor by Morgan Stanley and CICC
On January 29, 2024, Zhejiang Taimei Medical Technology Co., Ltd., Zhejiang Taimei Medical Technology Co., Ltd. (“Taimei Medical Technology” for short) from Jiaxing, Zhejiang submitted a prospectus on the Hong Kong Stock Exchange to go public for an IPO in Hong Kong.
No Data
No Data